09.05.2024 13:07:51 - dpa-AFX: *MERCK: HEALTH CANADA APPROVES KEYTRUDA + GEMCITABINE-BASED CHEMOTHERAPY FOR BILIARY TRACT CARCINOMA IN ADULTS

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
Merck & Co A0YD8Q NYSE 127,920 03.06.24 20:01:03 +2,380 +1,90% 127,880 127,920 125,130 125,540

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH